Novavax research chief Gregory Glenn told Reuters the company will start much larger late-stage clinical trials soon and could potentially glean enough data to obtain regulatory approvals as early as December.
No thanks I will takes my chances with covid
WJGunning Distraction from miserable failure.
Nothing as reassuring as a rushed vaccine. Wonder how many people will die from it.